Abstract
Fatigue which is modulated by many physiological and psychological factors is a major reason why most patients do not pursue consistent physical activity at recommended levels. Patients with Type 2 Diabetes (T2D) usually have inappropriate adiposity and inadequate physical activity. This study describes the links between adiposity, physical activity and self-reported fatigue in a group of Nigerian patients with T2D. Participants for this cross-sectional survey were a consecutive sample of 122 T2D patients assessed for adiposity (using body mass index and body fat percentage), physical activity (International Physical Activity Questionnaire) and self-reported fatigue (Iowa fatigue Scale). Seventy-seven (63.1 %) of the participants were overweight-to-obese, 50.8 % had very high body fat percentage, 49.2 % presented with a low level of physical activity and 78.6 % reported substantial-to-severe fatigue. Significant associations were found between self-reported fatigue and each of body mass index (χ 2 = 21.076; p = 0.002), body fat percentage (χ 2 = 19.214; p = 0.016) and physical activity (χ 2 = 33.332; p = 0.0001). Adjusted odds ratio for reporting substantial-to-severe fatigue was 2.49 (95 % CI = 1.99–3.98) for obese patients and 0.52 (95 % CI = 0.26–0.74) for those with moderate physical activity level. Most of the participants presented with adiposity, low physical activity level, and reported substantial-to-severe fatigue. Self-reported fatigue was significantly linked with adiposity and physical activity. Overweight, obesity, and high body fat percentage increased the risk of reporting substantial-to-severe fatigue while moderate-to-high physical activity level reduced the risk. Commitment to physical activity may help to reduce fatigue in overweight-to-obese T2D patients.
Similar content being viewed by others
References
Klein S, Sheard NF, Pi-Sunyer X, Daly A, Wylie-Rosett J, Kulkarni K, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr. 2004;80:257–63.
Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity: application to type 2 diabetes. Diabetes Care. 1997;20:1744–6.
Lim W, Hong S, Nelesen R, Dimsdale JE. The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med. 2005;165:910–5.
Cavelti-Weder C, Furrer R, Keller C, Babians-Brunner A, Solinger AM, Gast H, et al. Inhibition of IL-1β improves fatigue in type 2 diabetes. Diabetes Care. 2011;34:e158.
Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care. 1999;22:1266–72.
Fretts AM, Howard BV, Kriska AM, Smith NL, Lumley T, Lee ET, et al. Physical activity and incident diabetes in American Indians: The Strong Heart Study. Am J Epidemiol. 2009;170:632–9.
Hartz A, Bentler S, Watson D. Measuring fatigue severity in primary care patients. J Psychosom Res. 2003;54:515–21.
Meltzer LJ, Mindell JA. Impact of a child’s chronic illness on maternal sleep and daytime functioning. Arch Intern Med. 2006;166:1749–55.
Gozu A, Kern DE, Wright SM. Similarities and differences between international medical graduates and U.S. medical graduates at six Maryland Community-Based Internal Medicine Residency Training Programs. Acad Med. 2009;8:385–90.
International Physical Activity Questionnaire. 2005. www.ipaq.ki.se/contact/html. Accessed 6 Jan 2012.
Martin MV, Gomez GB, Antoranz GM, Fernandez HS, Gomez DL, de Oya OM. Validation of the Omron BF 300 monitor for measuring body fat by bioelectric impedance. Aten Primaria. 2001;28:174–81.
Omron Users’ Manual. Body fat monitor instruction manual. Omron Healthcare Company, Kyoto, Japan. 2004;4–7.
Gallagher D, Steven BH, Moonseong H, Susan AJ, Peter RM, Yoichi S. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72:694–701.
World Health Organization Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;157–163.
Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest. 1991;88:168–73.
Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM. The role of lipids in the pathogenesis of muscle insulin resistance and cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S189–91.
Zhu S, Wang Z, Shen W, Heymsfield SB, Heshka S. Percentage body fat ranges associated with metabolic syndrome risk: results based on the third National Health and Nutrition Examination Survey (1988–1994). Am J Clin Nutr. 2003;78:228–35.
Hayes L, White M, Unwin N, Bhopal R, Fischbacher C, Harland J, et al. Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK population. J Public Health. 2002;24:170–8.
Clark NG, Fox KM, Grandy S. Symptoms of diabetes and their association with the risk and presence of diabetes-findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Diabetes Care. 2007;30:2868–73.
Sivitz WI, Wayson SM, Bayless ML, Larson LF, Sinkey C, Bar RS, et al. Leptin and body fat in type 2 diabetes and monodrug therapy. J Clin Endocrinol Metab. 2003;88:1543–53.
Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin H, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85:115–8.
Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, Bock BC. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Arch Intern Med. 2008;168:14–6.
Resnick HE, Carter EA, Aloia M, Phillips B. Cross-sectional relationship of reported fatigue to obesity, diet, and physical activity: results from the third national health and nutrition examination survey. J Clin Sleep Med. 2006;2:163–9.
Eriksen W, Bruusgaard D. Do physical leisure time activities prevent fatigue? A 15 month prospective study of nurses’ aides. Br J Sports Med. 2004;38:331–6.
US Department of Health and Human Service. Physical activity and health: a report of the Surgeon General. In: US Centers for Disease Control and Prevention, National Center for chronic Disease Prevention and Health Promotion. 1996. http://wonder.cdc.gov/wonder/prevguid/m0042984/m0042984.asp/. Accessed 6 Dec 2011.
McIlvenny S, DeGlume AM, Elewa M, Fernandez OT, Dormer P. Factors associated with fatigue in a family medicine clinic in the United Arab Emirates. Fam Pract. 2000;17:408–13.
Moreh E, Jacobs JM, Stessman J. Fatigue, function, and mortality in older adults. J Gerontol A Biol Sci Med Sci. 2010;65A:887–95.
Acknowledgments
The authors are sincerely grateful to all the participants who took time out of their clinic schedule to fill out questionnaires and make themselves available for the adiposity measurements.
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Adeniyi, A.F., Ogwumike, O.O., Akinwonmi, A.O. et al. Links between adiposity, physical activity and self-reported fatigue in patients with type 2 diabetes mellitus. Int J Diabetes Dev Ctries 34, 144–149 (2014). https://doi.org/10.1007/s13410-013-0175-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-013-0175-6